|
Hepatitis E
| Treatment No. : |
CD0106 |
| Dosage & Instructions: |
15 drops in 15 ml of plain water twice a day,
mornings and evenings.
|
| Composition: |
Chelidonium D2+20C
Berb.Vulg D3+30C
Carduus Mar D2+20C
Kalmegh D1+10C
Myrica D10+100C
Hydrastis D2+20C
Chionanthus D2+20C
Podophylum D6+60C |
| Contra-Indications: |
None established |
| Storage: |
Store in a cool and dry place |
| Precautions: |
Keep away from the reach of children |
| Standard Packaging : |
30 ml Drops |
|
Order Online:
|
One 30 ml bottle for $79.99
Two 30 ml bottles for $129.99
|
Condition Overview:
The hepatitis E virus (HEV) is a common cause of hepatitis that is
transmitted via the intestinal tract, and is not caused by the hepatitis A
virus. Spread most often by contaminated drinking water, HEV infection occurs
mainly in developing countries.
Hepatitis E is also known as epidemic non-A, non-B hepatitis. Like hepatitis
A, it is an acute and short-lived illness that can sometimes cause liver
failure. HEV, discovered in 1987, is spread by the fecal-oral route. It is
constantly present (endemic) in countries where human waste is allowed to get
into drinking water without first being purified. Large outbreaks (epidemics)
have occurred in Asian and South American countries where there is poor
sanitation. In the United States and Canada no outbreaks have been reported, but
persons traveling to an endemic region may return with HEV.
There are at least two strains of HEV, one found in Asia and another in
Mexico. The virus may start dividing in the gastrointestinal tract, but it grows
mostly in the liver. After an incubation period (the time from when a person is
first infected by a virus until the appearance of the earliest symptoms) of two
to eight weeks, infected persons develop fever, may feel nauseous, lose their
appetite, and often have discomfort or actual pain in the right upper part of
the abdomen where the liver is located. Some develop yellowing of the skin and
the whites of the eyes (jaundice). Most often the illness is mild and disappears
within a few weeks with no lasting effects. Children younger than 14 years and
persons over age 50 seldom have jaundice or show other clinical signs of
hepatitis.
Hepatitis E never becomes a chronic (long-lasting) illness, but on rare
occasions the acute illness damages and destroys so many liver cells that the
liver can no longer function. This is called fulminant liver failure, and may
cause death. Pregnant women are at much higher risk of dying from fulminant
liver failure; this increased risk is not true of any other type of viral
hepatitis. The great majority of patients who recover from acute infection do
not continue to carry HEV and cannot pass on the infection to others.
HEV can be found by microscopically examining a stool sample, but this is not
a reliable test, as the virus often dies when stored for a short time. Like
other hepatitis viruses, HEV stimulates the body's immune system to produce a
substance called an antibody, which can swallow up and destroy the virus. Blood
tests can determine elevated antibody levels, which indicate the presence of HEV
virus in the body. Unfortunately, such antibody blood tests are not widely
available.
There is no way of effectively treating the symptoms of any acute hepatitis,
including hepatitis E. During acute infection, a patient should take a balanced
diet and rest in bed as needed.
Most attempts to use blood serum containing HEV antibody to prevent hepatitis
in those exposed to HEV have failed. Hopefully, this approach can be made to
work so that pregnant women living in endemic areas can be protected. No vaccine
is available, though several are being tested. It also is possible that
effective anti-viral drugs will be found. The best ways to prevent hepatitis E
are to provide safe drinking water and take precautions to use sterilized water
and beverages when traveling.
|